176 The Positive Glucose Breath Test: Small Bowel Bacterial Overgrowth or Colonic Fermentation?

2014 ◽  
Vol 146 (5) ◽  
pp. S-46
Author(s):  
Emery C. Lin ◽  
Benson T. Massey
Keyword(s):  
Small Bowel ◽  
Breath Test ◽  
Bacterial Overgrowth ◽  
Colonic Fermentation ◽  
Small Bowel Bacterial Overgrowth ◽  
Glucose Breath Test

GLUCOSE BREATH TEST FOR DETECTION OF SMALL BOWEL BACTERIAL OVERGROWTH IN DIABETIC PATIENTS

2004 ◽  
Vol 99 ◽  
pp. S60
Author(s):  
Yoshihisa Urita ◽  
Yoshinori Kikuchi ◽  
Kazuo Hike ◽  
Naotaka Torii ◽  
Eiko Kanda ◽  
...  
Keyword(s):  
Small Bowel ◽  
Breath Test ◽  
Bacterial Overgrowth ◽  
Diabetic Patients ◽  
Small Bowel Bacterial Overgrowth ◽  
Glucose Breath Test

Use of the lactose-[13C]ureide breath test for diagnosis of small bowel bacterial overgrowth: comparison to the glucose hydrogen breath test

2009 ◽  
Vol 44 (9) ◽  
pp. 944-951 ◽  
Author(s):  
Heiner K. Berthold ◽  
Patrick Schober ◽  
Christian Scheurlen ◽  
Günter Marklein ◽  
Regine Horré ◽  
...  
Keyword(s):  
Small Bowel ◽  
Breath Test ◽  
Bacterial Overgrowth ◽  
Hydrogen Breath Test ◽  
Small Bowel Bacterial Overgrowth

The 13C-Xylose Breath Test for the Diagnosis of Small Bowel Bacterial Overgrowth in Children

1997 ◽  
Vol 25 (2) ◽  
pp. 153-158 ◽  
Author(s):  
Susan F. Dellert ◽  
Michael J. Nowicki ◽  
Michael K. Farrell ◽  
Jacques Delente ◽  
James E. Heubi
Keyword(s):  
Small Bowel ◽  
Breath Test ◽  
Bacterial Overgrowth ◽  
Small Bowel Bacterial Overgrowth

Treatment of Small Intestine Bacterial Overgrowth with Rifaximin, a Non-Absorbable Rifamycin

1988 ◽  
Vol 16 (4) ◽  
pp. 312-316 ◽  
Author(s):  
G. R. Corazza ◽  
M. Ventrucci ◽  
A. Strocchi ◽  
M. Sorge ◽  
L. Pranzo ◽  
...  
Keyword(s):  
Small Intestine ◽  
Side Effects ◽  
Small Bowel ◽  
Therapeutic Efficacy ◽  
Breath Test ◽  
Bacterial Overgrowth ◽  
Hydrogen Breath Test ◽  
Small Bowel Bacterial Overgrowth ◽  
Small Intestine Bacterial Overgrowth ◽  
Lactulose Hydrogen Breath Test

In twelve patients affected by small bowel bacterial overgrowth, diagnosed by means of the lactulose hydrogen breath test, the therapeutic efficacy of a non-absorbable derivative of rifamycin, rifaximin, was evaluated. This study showed that this drug has a satisfactory therapeutic efficacy in contaminated small bowel syndrome and, at the doses tested, is free of side-effects.

Sign in / Sign up

Export Citation Format

Share Document